Translation Is Required to Remove Y14 from mRNAs in the Cytoplasm  by Dostie, Josée & Dreyfuss, Gideon
Current Biology, Vol. 12, 1060–1067, July 9, 2002, 2002 Elsevier Science Ltd. All rights reserved. PII S0960-9822(02)00902-8
Translation Is Required to Remove Y14
from mRNAs in the Cytoplasm
of the hnRNP proteins have been found to function in
mRNA translation, stability, or mRNA localization in the
cytoplasm [3, 6–10].
In addition to the proteins that bind pre-mRNAs co-
transcriptionally or shortly thereafter, splicing both re-
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moves and recruits specific proteins to the mRNA. These
recruited proteins, in the form of a multiprotein complex
are assembled in a sequence-independent, position-Summary
specific manner, near (20 nt upstream of) exon-exon
junctions [11–15]. Several components of this complex,Background: Y14 is an RNA binding protein which is
called the exon-exon junction complex (EJC), have beenpart of a multiprotein complex, the exon-exon junction
identified and include SRm160 [12, 16], DEK [17], RNPS1complex (EJC), that assembles on the exon-exon junc-
[18], Aly/REF [19], Y14 [11], magoh [20], and Upf3 [21,tions of mRNAs produced by splicing. The position-
22] (Figure 1A). SRm160 is a splicing enhancer rich inspecific binding of Y14 persists on mRNAs after their
serine-arginine (SR) repeats, which functions by inter-export to the cytoplasm. Thus, Y14, together with its
acting with snRNPs, and SR proteins [16]. RNPS1 is ainteracting proteins, has the capacity to communicate
splicing coactivator and contains an RNA binding motifto the cytoplasm the processing history of the mRNA,
(RBD) [18]. DEK may also be a component of the EJC.including the position of the removed introns, informa-
It copurifies with SR proteins and interacts with SRm160tion that is likely to be important for defining premature
in vitro, but its interactions are not exclusive to mRNAs,termination codons. How Y14 and other components of
as it also binds pre-mRNAs [17].the EJC are removed from mRNAs into the cytoplasm
In the nucleus, the EJC stimulates mRNA export [19,has not been determined.
23]. This activity may be mediated, at least in part, byResults: We show that Y14 but not another EJC compo-
the RNA binding protein Aly/REF, which binds the mRNAnent, Aly/REF, is present in polysome profile fractions
export factor TAP (Figure 1B). Mammalian Aly/REF cancontaining one ribosome per mRNA. Using reporter con-
bind directly to both TAP and RNA at the same time [24],structs in an in vitro splicing/translation-coupled sys-
and microinjection of recombinant Aly/REF in Xenopustem, we show that Y14 remains associated with untrans-
oocytes enhances export of spliced mRNAs [19]. Tem-lated mRNAs but is removed from translationally active
perature-sensitive mutants of Yra1p, the S. cerevisiaemRNAs. Importantly, mRNAs whose translation in vivo
homolog of Aly/REF, are impaired in poly(A) RNA exportis prevented by the presence of strong secondary 5
[25]. However, the nuclear export of both spliced andUTR structure retain Y14 in the cytoplasm.
unspliced mRNAs was inhibited by injection of anti-Aly/Conclusions: These findings indicate that Y14 remains
REF antibodies, suggesting that this protein might alsoassociated with mRNAs in the cytoplasm until they are
function in the nuclear export of intronless mRNAs [26].translated, and translation is required to remove Y14
The EJC is highly dynamic, and several of its proteins,
from mRNAs. Thus, the process of translation removes
Aly/REF, Y14, magoh, RNPS1, and Upf3, shuttle be-
the splicing-dependent EJC protein imprints, which
tween the nucleus and cytoplasm [11, 19, 21, 22], while
most likely function in the surveillance of mRNAs to others, including SRm160, do not appear to shuttle [22].
define premature termination codons and possibly also Only Y14 and possibly magoh, RNPS1, and Upf3 remain
in modulating the translation activity of cytoplasmic associated with newly exported mRNAs in the cyto-
mRNAs. plasm (Figure 1C). Aly/REF dissociates from mRNAs
during or immediately after export [27], and although
Introduction Upf3 and RNPS1 were found in RNP complexes con-
taining Y14, Aly/REF, and TAP [21, 22], these proteins
Although transcription and splicing can be uncoupled may not persist on mRNAs in the cytoplasm [23].
in vitro, pre-mRNAs are predominantly spliced cotrans- The final removal of Y14 and of other putative compo-
criptionally in vivo [1]. Nascent transcripts become asso- nents of the cytoplasmic EJC (cEJC) from mRNAs has
ciated with hnRNP proteins and components of the been suggested but not previously demonstrated to be
splicing machinery including snRNPs. The hnRNP pro- mediated by the translation machinery (Figure 1D). This
teins that bind to chromatin-associated pre-mRNAs par- suggestion has been made in an attempt to explain the
ticipate in various nuclear events, such as transcription requirement for both pre-mRNA splicing and translation
regulation, alternative splicing, and 3 end processing in the recognition of premature stop codons (PTCs) and
[2, 3]. Whereas snRNPs dissociate from spliced mRNAs, activation of the nonsense-mediated degradation of
many of the hnRNP proteins remain associated with mRNAs that bear PTCs [28, 29]. Because Y14 remains
spliced mRNAs in the nucleus, and the majority of these on the mRNAs after export to the cytoplasm in the same
also accompany mRNAs to the cytoplasm, suggesting a position, near exon-exon junctions, it has the necessary
role for these proteins in mRNA export and cytoplasmic attributes to serve as a mark that could communicate
mRNA metabolism [4, 5]. Consistent with this, several to the translation machinery in the cytoplasm informa-
tion that is needed to distinguish between PTCs and
legitimate termination codons. Here we show that Y141Correspondence: gdreyfuss@hhmi.upenn.edu
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Figure 1. Schematic Representation of the
Formation, Transport, and Removal of the
EJC from mRNAs
See text for details.
is found on mRNAs in the cytoplasm of somatic cells. Xenopus oocytes [11]. The splicing substrates used in
In particular, Y14 is present in polysome profile fractions previous experiments did not contain an open reading
corresponding to mRNAs that are associated with one frame encompassing the exon-exon junctions, as is the
ribosome. We developed an assay to analyze the re- case for most cellular mRNAs. Thus, it seemed possible
quirement for translation for the removal of Y14. We that these substrates did not behave as natural mRNAs
show both in vitro and in vivo that mRNA translation is with regards to their interaction with the translation ma-
required to remove Y14 from spliced cytoplasmic chinery. Consequently, it was not clear whether Y14
mRNAs. These findings support the conclusion that Y14, persists on mRNAs until they engage the translation
likely together with magoh, RNPS1, and Upf3, serves machinery in the cytoplasm, and whether translation is
as the splicing-dependent marker that communicates required to remove Y14 from mRNAs. Furthermore,
to the translation machinery in the cytoplasm the infor- these studies were carried out in Xenopus oocytes, and
mation necessary for surveillance of PTCs and thus for similar information on somatic cells was thus not
activation of NMD. available.
To determine whether Y14 is present in fractions con-
taining mRNAs associated with ribosomes in somaticResults
cells, cytoplasmic extracts from HeLa cells were pre-
pared and resolved by sedimentation on sucrose gradi-Y14 Cosediments with Cytoplasmic mRNAs
ents. The RNA content in the collected fractions wasAssociated with Monosomes
analyzed by spectrophotometry to identify the positionPrevious studies demonstrated that the splicing-depen-
of ribosomal complexes [monosomes (80S) and poly-dent position-specific binding of Y14 on mRNAs exon-
exon junctions persists after export to the cytoplasm in somes; Figure 2A, upper panel]. The presence of ribo-
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Figure 2. Endogenous Y14 Cosediments with mRNAs Associated with Monosomes
(A) (Upper panel) Optical density profile from 15%–40% sucrose gradient of cytoplasmic HeLa cell extract. x axis represents the fraction
number, and y axis the optical density at 254 nm. Fraction numbers are from top (fraction 1) to bottom (fraction 22) of gradient. (Lower panel)
Agarose gel analysis of fractions 2 to 21.
(B) Immunoblotting analysis of gradient fractions. Total proteins from each fraction were resolved by SDS-PAGE and analyzed by Western
blotting with anti-PABP 10E10 (top), anti-Aly/REF 11G5 (middle), and anti-Y14 1F12 (bottom). This experiment was reproduced four times
under various experimental conditions. Pellet represents sedimented proteins.
(C and D) Experiment was done as in (A) and (B), except that cells were first treated with puromycin (0.1 mg/ml) for 2 hr.
somal RNA was also verified by agarose gel electropho- Translation Is Required to Remove Y14 from
mRNAs In Vitroresis (Figure 2A, lower panel). The proteins in the same
fractions were resolved by SDS-PAGE and analyzed for To determine whether mRNA translation is required for
the removal of bound Y14 from mRNAs, we developedthe presence of Y14 and other components by immu-
noblotting with the indicated antibodies (Figure 2B). Fig- an in vitro splicing/translation-coupled assay, using re-
porter constructs. The splicing substrate derived fromure 2B shows that most of the cytoplasmic Y14 and Aly/
REF is present in ligther complexes at the top of the the chicken -crystallin pre-mRNA (CDC) and its corre-
sponding mRNA has been extensively characterized ingradient. However, Y14 displayed a second peak in the
80S (monosome) region (Figure 2B; dashed box), which vitro and in vivo [11, 27, 30]. However, this substrate
did not contain an open reading frame. We thereforewas sensitive to puromycin treatment of the cells,
whereas the sedimentation profile of Aly/REF was not modified the CDC pre-mRNA and mRNA to include an
AUG that would serve as a translation initiation codonaffected under these conditions (Figures 2C and 2D).
Likewise, we found that cosedimentation of Y14 with at the beginning of exon 1 and a flag-encoding sequence
with a TGA termination codon at the end of exon 2 (pre-80S particles is sensitive to EDTA (data not shown). The
presence of the poly(A) binding protein PABP in the CDC and CDCm; Figure 3A).
To monitor the effect of translation on the associationgradient fractions was analyzed as control for the sedi-
mentation profile to monitor the presence of mRNA. of Y14 with the modified CDC, a stable hairpin structure
of estimated G 30.3 kcal/mole was inserted up-These results are in good agreement with previous re-
ports indicating that Y14 but not Aly/REF remains stably stream of the AUG in exon 1 (5-secpre-CDC and 5-
sec-CDCm; Figure 3A). This secondary structure wasbound to mRNAs in the cytoplasm [27] and suggests that
Y14 interaction persists at least until the initial stages previously shown to efficiently inhibit mRNA translation
both in vitro and in vivo [31]. Stable secondary structureof association between the mRNA and the translation
machinery. insertion in the 5 UTR of the modified CDC constructs
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Figure 3. The Stable RNA Secondary Structure 5-sec Inhibits Translation of CDCm when Placed in its 5 UTR
(A) Schematic representation of the novel CDC splicing substrates (pre-CDC and 5-secpre-CDC) and corresponding intronless mRNAs (CDCm
and 5-sec-CDCm). Numbers below each construct represents sizes (nt) of 5 UTR, exons (E1 and E2), and intron (IVS). Position, predicted
structure, and sequence of 5-sec are shown in enlargement. Proposed 5-sec secondary structure was predicted by the mFold algorithm
[37, 38].
(B) In vitro translation of [35S]methionine 5-sec-CDCm and CDCm in rabbit reticulocyte lysate. Total (left) or anti-Flag immunoprecipitated
(right) translation products were resolved by SDS-PAGE and revealed by autoradiography.
(C) Agarose gel analysis of capped 5-sec-CDCm and CDCm input RNAs used in (B).
rather than general translation inhibitors was used to 5 to 8). Total, immunoprecipitated, and unbound RNAs
were extracted and resolved by electrophoresis on de-inhibit translation in order to achieve a more complete
and reproducible block in protein synthesis. To verify naturating polyacrylamide gels. In agreement with previ-
ous studies, Figure 4A shows that Y14 was preferentiallythat this stable secondary structure also efficiently inhib-
its translation of CDCm, equal amounts of capped 5- associated with spliced mRNAs (lanes 6 and 8) and
importantly that Y14 bound equally well to 5-sec-CDCmsec-CDCm and CDCm mRNAs were incubated in rabbit
reticulocyte lysates translation system containing and CDCm produced by splicing (compare lanes 6 and
8). The interaction of Y14 with mRNAs was splicing de-[35S]methionine (Figure 3C). Total (Figure 3B, left) and
anti-Flag immunoprecipitated (right) protein products pendent, as no significant amount of 5-sec-CDCm or
CDCm processed as above was immunoprecipitatedwere resolved by SDS-PAGE and visualized by autoradi-
ography. Figure 3B shows that protein was produced with the anti-Y14 antibody (Figure 4B, lanes 5 to 8). Since
these new splicing substrates are efficiently spliced,from CDCm but not from 5-sec-CDCm, indicating that
the secondary structure efficiently inhibits translation of associate with Y14 in a splicing-dependent manner, and
contain a regulated open reading frame which is recog-5-sec-CDCm in vitro, and that the open reading frame
introduced in CDCm is indeed translated. nized by the translation machinery, this system is suit-
able to analyze the role of the translation machinery inBecause modification of the CDC sequence might
affect splicing efficiency of the substrates, the relative the removal of Y14 from mRNAs.
To determine whether translation is required to re-activity of 5-secpre-CDC and pre-CDC was examined
in vitro. The relative splicing efficiency of the substrates move Y14 from spliced mRNAs, 5-secpre-CDC and pre-
CDC splicing reactions were incubated in rabbit reticulo-was found to be similar and comparable to the original
CDC (data not shown). As changes in the CDC sequence cyte lysates before immunoprecipitation. During this
step, CDCm but not 5-sec-CDCm will be translated,might also affect assembly of exon-exon junction com-
plexes, the interaction of Y14 with the novel splicing and if translation is required to remove Y14 from the
spliced mRNAs, more 5-sec-CDCm should be immuno-substrates was characterized. Aliquots from splicing re-
actions of capped 5-secpre-CDC and pre-CDC were precipitated with the anti-Y14 (4C4) antibody. Figure 4C
shows that after translation considerably more Y14 wascollected to verify splicing efficiency (Figure 4A, lanes
3 and 4). The remaining reaction volumes were used in associated with untranslated 5-sec-CDCm as com-
pared to CDCm. Thus, these results suggest that transla-immunoprecipitation experiments with anti-Y14 (4C4)
and a nonimmune antibody (SP2/0) as a control (lanes tion can remove Y14 from mRNAs in vitro.
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Figure 4. mRNA Translation Is Required to Remove Y14 from mRNAs In Vitro
(A) Characterization of the relative splicing efficiencies and association of Y14 on 5-secpre-CDC and pre-CDC splicing substrates. 32P-labeled
5-secpre-CDC or pre-CDC (unspliced; lanes 1 and 2) were incubated in HeLa nuclear splicing extracts (spliced inputs, lanes 3 and 4) and
used in immunoprecipitation experiments with the indicated antibodies (IP, lanes 5 to 8).
(B) Y14 does not associate with intronless 5-sec-CDCm and CDCm. Experiments were done as in (A), except that 32P-labeled intronless 5-
secCDCm and CDCm were used in this assay.
(C) Splicing reactions of 32P-labeled 5-secpre-CDC or pre-CDC (unspliced; lanes 1 and 2) were incubated in rabbit reticulocyte lysates (spliced
inputs, lanes 3 and 4) and used in immunoprecipitation experiments with the indicated antibodies (IP, lanes 5 to 8). Splicing products and
intermediates are indicated on the right. Splicing input (lanes 3 and 4 of panels [A]–[C]) represents 10% of material used in immunoprecipitations,
and lanes 9 to 12 represent 10% of the material recovered after immunoprecipitation (FT, flowthrough; M, molecular weight marker).
Removal of Y14 from Cytoplasmic mRNAs In Vivo used to detect spliced 5-sec-CDCm and CDCm did not
encompass the 5 untranslated region (5UTR), and thusRequires Translation
The results presented in Figure 4 suggest that the bind- protected fragments from either constructs should be of
the same size. Figure 5 shows that although comparableing of Y14 persists on mRNAs in the cytoplasm until
the mRNAs are engaged by the translation machinery. amounts of 5-sec-CDCm and CDCm were generated
(lanes 6 and 9), Y14 was associated almost exclusivelyHowever, in this system, spliced mRNAs are directly
accessible to the protein synthesis machinery rather with the translationally inactive 5-sec-CDCm. The asso-
ciation of Y14 with 5-sec-CDCm and CDCm was splic-than first undergoing nuclear export through the nuclear
pore complex. Consequently, it is possible that the com- ing dependent, since only low levels of Ad2m were im-
munoprecipitated with the anti-Y14 antibody (lanes 5,position of the post-export exon-exon junction com-
plexes might be different from that of complexes pro- 8, and 11). Together, these results demonstrate that Y14
remains associated with mRNAs in the cytoplasm untilduced by splicing in vitro. To address the possibility
that translation is required to remove Y14 from mRNAs the mRNAs engage the translation machinery and that
cytoplasmic translation is required to remove Y14 fromin vitro because it is more stably bound to transcripts
in the presence of other complex components, the re- mRNA exon-exon junctions.
quirement of translation was analyzed in vivo. 293T cells
were cotransfected with the intronless reporter con- Discussion
struct Ad2m and either pcDNA3, 5-secpre-CDC, or pre-
CDC. Ad2m served as a control for transfection effi- We show here that Y14 is present in polysome profile
fractions corresponding to mRNAs that are associatedciency and for Y14 binding specificity. Transfected cells
were treated with digitonin to prepare cytoplasmic ly- with one ribosome in the cytoplasm of somatic cells.
This suggests that Y14 remains bound to spliced mRNAssates. Cytoplasmic extracts were used in immunopre-
cipitation experiments with the indicated antibodies, in the cytoplasm at least until the mRNAs engage the
translation machinery. Previous experiments in Xenopusand bound RNAs were analyzed by RNase protection
assay with RNA antisense probes. The antisense probe oocytes have shown that Y14 and its tightly associated
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and RNPS1 in ribosome-containing mRNPs is consis-
tent with their role in providing the splicing-dependent
imprints that distinguish PTCs from bona fide stop co-
dons for the translation machinery in the cytoplasm. To
explain the functional link between splicing and transla-
tion, we previously suggested that Y14 and more re-
cently also magoh and Upf3 remain stably associated
with spliced mRNAs in the cytoplasm at the exon-exon
junctions, at least until the first round of translation [11,
20, 21]. However, the splicing substrates used in previ-
ous studies to address this issue did not contain open
reading frames encompassing the exon-exon junction,
and this issue could therefore not be addressed. It is
possible that the stability of the association of Y14 with
cytoplasmic mRNAs in Xenopus oocytes is due to the
absence of an open reading frame in the splicing sub-
strates used and consequently in the inability of these
mRNAs to recruit and be translated by 80S ribosomal
complexes (assembled ribosomes; for review, see [34]).
Since injected mRNAs without open reading frames
likely undergo translation initiation, the process by
which the initiator AUG is recognized, Y14 complexes
might only be removed from mRNAs by ribosomes dur-
ing the elongation phase and not by the small (40S)
ribosomal subunit during the initiation phase of protein
synthesis. Interestingly, numerous mRNAs contain in-
trons within their 5 UTRs. Thus, it will be important
to determine whether the Y14 complex is assembled
upstream of exon-exon junctions in the 5 UTR of these
mRNAs and if the translation initiation process is suffi-Figure 5. mRNA Translation Is Required to Remove Y14 from Cyto-
cient to remove this complex from mRNAs.plasmic mRNAs In Vivo
We show here in vitro and in vivo that Y14 does notCytoplasmic extracts from HEK293T cells cotransfected with
significantly associate with a translating mRNA pro-pAd2m and either pcDNA3 (lanes 3 to 5), 5-secpre-CDC (lanes 6
to 8), or pre-CDC (lanes 9 to 11) were used in immunoprecipitation duced by splicing but that it remains bound to a transla-
experiments with the indicated antibodies. Bound RNAs were ex- tionally silent mRNA in the cytoplasm. Thus, translation
tracted and analyzed by RNase protection assay with RNA antisense is required to remove Y14 from mRNAs in the cytoplasm.
probes. Lane 1 represents 0.5% of input probes used in the assay. The observation that Y14 is bound to mRNAs associated
Protected fragment of Ad2m and CDCm are indicated on the right.
with ribosomes also raises the possibility that it has aCoimmunoprecipitated 5-sec-CDCm (lane 8) and CDCm (lane 11)
role in mRNA translation. Pre-mRNA splicing was pre-represents 60% and 4% of input, respectively. Lane M, molecular
weight marker. viously shown to enhance mRNA translation activity [35].
Of the known cytoplasmic EJC components, Y14 and
magoh are the best candidates to mediate this activity.
protein magoh assemble into the exon-exon junction It will be interesting to determine whether these proteins
complex (EJC) and are present on mRNAs after their or other as yet unidentified cEJC components are re-
export to the cytoplasm. This suggested that Y14, to- sponsible for this activity. The in vitro splicing/transla-
gether with magoh, could provide the critical link be- tion-coupled system should be a useful tool to charac-
tween splicing and translation and thus function in non- terize these functional aspects of the cEJC.
sense-mediated mRNA decay (NMD). NMD is a process
by which mRNAs containing mutations that cause pre- Conclusions
mature termination codons (PTC) are selectively de- We demonstrated that the EJC protein Y14 remains as-
graded [32]. A further link between Y14 and NMD was sociated with mRNAs until mRNAs engage ribosomes
provided by the observation that Y14 interacts with the in the cytoplasm. Using a novel in vitro splicing/transla-
NMD factor Upf3 and that Upf3 is also part of the EJC tion-coupled system, we found that translation is re-
[21]. Another EJC component, RNPS1, has been shown quired to remove Y14 from spliced mRNAs. We further
to interact with Upf3 [19] and thus is also likely to partici- showed that Y14 remains bound to translationally silent
pate in mRNA surveillance. Upf3 is predominantly nu- mRNAs but not to translated mRNAs in vivo.
clear and thought to recruit Upf2 upon nuclear export
Experimental Procedures[33]. Upf2 is also an essential factor in NMD and it inter-
acts, in addition with Upf3, with the NMD factor Upf1,
Plasmidsa protein associated with eukaryotic translation release
Pre-CDC and CDCm were generated by polymerase chain reaction
factors, which is required to trigger NMD of PTC-con- (PCR) using pCDC and pCDCm as templates, respectively [11]. Prim-
taining mRNAs. ers were designed to include an KpnI site and ATG or an XhoI site,
Flag sequence, and TGA in the forward and reverse oligonucleo-The presence of Y14 and possibly also magoh Upf3
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tides, respectively, to introduce an open reading frame in the re- at 4C. Complexes were washed five times with HNT buffer and
treated with proteinase K for 30 min at 37C. RNAs were extractedporter constructs. 5-secpre-CDC and 5-sec-CDCm were gener-
ated as described above, except that the following sequence was with phenol/chloroform and analyzed on denaturating 6% polyacryl-
amide gels. Immunoprecipitation from splicing/translation-coupledincluded in the forward primer: 5-CCGGATCCGGCCGGATCCGGC
CGGATCCGG-3. PCR products were subcloned into pcDNA3 (In- samples was performed as above, except that samples were diluted
with three volumes of HNT buffer prior incubation with antibodies.vitrogen), and sequences were verified by automated DNA cycle
sequencing. The plasmid pAd2m was previously described [11].
Transient Transfections and Cell Extracts
HEK293 cells were plated on 100 mm dishes, and grown in completePolysome Profile
HeLa S3 cells were grown in suspension in Dulbecco’s modified DMEM. At 50% confluency, cells were transfected with plasmid
DNA (2 g) using Geneporter (GTS Technologies) according to theEagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS; complete DMEM). Mid-log phase cells were collected by cen- manufacturer’s recommendations. At 24 hr posttransfection, cells
were washed twice with cold PBS, collected by scapping, and cen-trifugation at 1000  g for 20 min at 4C. Cell pellet was washed
with cold phosphate-buffered saline (PBS) containing 100 g/ml trifuged at 1000 g for 15 min at 4C. Cell pellets were resuspended
in RSB 100 (10 mM Tris-HCl [pH 7.4], 2.5 mM magnesium chloride,cycloheximide (Sigma) and with RSB 250 (10 mM Tris-HCl [pH 7.4],
2.5 mM magnesium chloride, 250 mM sodium chloride, 100 g/ml 100 mM sodium chloride, 0.9 units/l RNAsin, and protease inhibi-
tors [CompleteTM; Roche]) containing 35 g/ml digitonin. Cells werecycloheximide). Cells were resuspended in one volume of RSB 250
containing 35 g/ml digitonin (Calbiochem) and protease inhibitors incubated on ice for 5 min and disrupted by gentle passage through
a 25 gauge needle (4X). Extracts were centrifuged at 3000  g for(CompleteTM; Roche), incubated on ice for 5 min, and disrupted
by gentle passage through a 25 gauge needle (4X). Extract was 40 s at 4C to pellet nuclei and debris, and cytoplasmic lysates
were clarified by centrifugation at 11,000  g for 15 min at 4C.centrifuged at 3000  g for 40 s at 4C to pellet nuclei and debris,
and cytoplasmic lysate was clarified by centrifugation at 11,000  g Immunoprecipitations and RNA extractions were performed as de-
scribed above.for 15 min at 4C. Supernatant was resolved on a 15%–40% sucrose
gradient prepared in RSB 250 containing protease inhibitors. The
sucrose gradient was centrifuged at 5C in a Beckman SW41.1 rotor RNase Protection Assay
at 18,000  g for 18 hr. Following centrifugation, fractions were To prepare in vitro transcription templates, CDCm and pAd2m were
collected from the top of the gradient with a BioComp fractionator. linearized with KpnI and HindIII, respectively. Linearized plasmids
Fractions were analyzed by immunoblotting as described below. were agarose-gel purified (Qiagen), and antisense mRNAs were gen-
erated with SP6 polymerase, according to the manufacturer’s in-
structions (Promega). Preparation of 32P-UTP-RNA probes was per-Antibodies and Immunoblotting
Anti-Y14 antibodies, 1F12 (immunoblotting), and 4C4 (immuno- formed as previously described [36]. Extracted RNAs from
transiently transfected HEK293T cells were assayed by RNase pro-precipitation) were previously described [27]. Anti-PABP, 10E10,
anti-Aly, 11G5 [27], and nonimmune mouse IgG, SP2/0 [11], were tection assay with radiolabeled probes as described by the manu-
facturer (RPA II kit; Ambion). Protected fragments were analyzeddescribed elsewhere. Peroxidase-coupled anti-mouse IgG was pur-
chased from Jackson ImmunoResearch Laboratories. on denaturating 6% polyacrylamide gels.
For immunoblotting, polypeptides were resolved on sodium dode-
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